Lung Cancer | Norton Healthcare

Indication: Lung Cancer

Determination and Validation of Lung EpiCheck a Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study.

Sub-indication: Lung Cancer

Study Type: Observational

Principal Investigator: John Hamm, M.D.
Norton Cancer Institute

Sponsor: Sponsor: Nucleix, Inc

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.